Latest Articles

Neurotransmitter Testing Holds Keys to Understanding Chronic Inflammation

By Decker Weiss, NMD, FASA, Contributing Writer

Clinically, we blame most chronic diseases on inflammation. Yet the ways we diagnose, measure, and monitor diseases associated with inflammation--including heart disease and cancer-- have not evolved to a truly clinically useful level. By looking upstream at neurotransmitter levels, we can gain important information about what's really happening with our patients. 

How Transformative Tech & Renegade Retail Will Reform Healthcare

By Erik Goldman

The next wave of healthcare reform won’t be coming from the federal government, the insurance industry, the hospital systems, or medical academia. In fact, the driving forces already reshaping healthcare aren’t coming from within healthcare at all, but from the world’s biggest tech and finance companies on one side, and good old-fashioned grass-roots consumerism on the other.

Can Probiotics Regulate Lipid Metabolism?

By Carrie Decker, ND, Contributing Writer

There’s ample data to show that gut bacteria affect mood, immune system health, sleep cycles, and response to stress. It turns out that the gut microbiome—at least certain microbial species within it—also play a role in lipid metabolism, suggesting that some types of probiotics may have heart health benefits.

Low Folate, MTHFR Polymorphisms Raise Risk of Congenital Heart Defects

By Kristen Schepker, Assistant Editor

Low folate status, combined with a cluster of certain folate-metabolizing genetic variants, is associated with increased risk of congenital heart disease (CHD). Mothers and children with certain polymorphisms within the MTHFR, MTR, and MTRR genes showed decreased folate and elevated homocysteine levels, both significant risk factors for CHD.

Bar Wars: The Un-Sugarcoated Truth About the Clif vs KIND Controversy

By Ellen Kanner, Contributing Writer

On March 6, New York Times subscribers came upon a full-page open letter—in print and online-- from the popular snack food company Clif Bar, challenging competing brand, KIND, to live up to its name and go completely organic. Was this an earnest plea for corporate responsibility or a shrewd marketing ploy? Either way, the ensuing "bar fight" underscores both the massive size of the "healthy" snack market, and the rapid growth of consumer demand for healthy and eco-friendly foods. 

Is Leaky Gut a Cardiovascular Risk Factor?

By Becky Wright, Contributing Writer

Leaky gut syndrome has been getting a lot of attention during the last several years for its role in the etiology of chronic conditions like inflammatory bowel syndrome (IBS) and even diabetes. A new line of research suggests that intestinal permeability may contribute to cardiovascular risk. The key? Gut bacteria and bacterial endotoxins that enter the blood stream and inflitrate the epicardium, the vascular endothelium, and atheromatous plaques present in the vessels.

Help celebrate our 20th year at TPC Forum at the TWA Hotel April 23 at 6pm
Help celebrate our 20th year at TPC Forum at the TWA Hotel April 23 at 6pm